-
1.
公开(公告)号:US20130281657A1
公开(公告)日:2013-10-24
申请号:US13879513
申请日:2011-10-13
CPC分类号: C07K7/64 , C07D277/42 , C07D417/04 , C07K1/1136 , C07K5/123 , C07K5/126
摘要: The invention provides methods of preparing macrocycles including macrocycle stabilized peptides (MSPs). Macrocycles and MSPs are prepared according to nucleophilic capture of an iminoquinomethide type intermediate generated from a suitably substituted 2-amino-thiazol-5-yl carbinol. The preferred nucleophile may be selected from an electron rich aromatic moiety in the case of macrocycles and, in the case of MSPs, at least one amino acid comprises an electron rich aromatic moiety. In addition, the concept can be extended to other related 5-membered heterocyclic systems in place of the thiazole, such as imidazole or oxazole. The conditions for the generation of the corresponding iminoquinomethide type intermediates may be similar or different than the conditions used for the 2-amino-thiazol-5-yl carbinol.
摘要翻译: 本发明提供了制备大环化合物包括大环稳定肽(MSP)的方法。 根据由适当取代的2-氨基 - 噻唑-5-基甲醇产生的亚氨基喹喔啉型中间体的亲核捕获制备大环和MSP。 在大环化合物的情况下,优选的亲核试剂可以选自富含电子的芳族部分,在MSP的情况下,至少一个氨基酸包含富电子的芳族部分。 此外,该概念可以扩展到其它相关的5元杂环体系代替噻唑,例如咪唑或恶唑。 产生相应的亚氨基喹喔啉型中间体的条件可以与用于2-氨基 - 噻唑-5-基甲醇的条件相似或不同。
-
公开(公告)号:US20120302747A1
公开(公告)日:2012-11-29
申请号:US13568750
申请日:2012-08-07
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: C07D487/04 , C07D491/08
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制酪氨酸激酶活性,从而使它们用作抗癌剂和治疗阿尔茨海默氏病。
-
公开(公告)号:US20080009497A1
公开(公告)日:2008-01-10
申请号:US11773466
申请日:2007-07-05
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: A61K31/53 , A61P35/00 , C07D403/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制酪氨酸激酶活性,从而使它们用作抗癌剂和治疗阿尔茨海默氏病。
-
公开(公告)号:US08592579B2
公开(公告)日:2013-11-26
申请号:US13568750
申请日:2012-08-07
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: C07D487/04 , C07D401/14 , A61K31/53 , A61P35/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
-
公开(公告)号:US09169295B2
公开(公告)日:2015-10-27
申请号:US13879513
申请日:2011-10-13
IPC分类号: C07K7/64 , C07K5/12 , C07D277/42 , C07D417/04 , C07K1/113
CPC分类号: C07K7/64 , C07D277/42 , C07D417/04 , C07K1/1136 , C07K5/123 , C07K5/126
摘要: The invention provides methods of preparing macrocycles including macrocycle stabilized peptides (MSPs). Macrocycles and MSPs are prepared according to nucleophilic capture of an iminoquinomethide type intermediate generated from a suitably substituted 2-amino-thiazol-5-yl carbinol. The preferred nucleophile may be selected from an electron rich aromatic moiety in the case of macrocycles and, in the case of MSPs, at least one amino acid comprises an electron rich aromatic moiety. In addition, the concept can be extended to other related 5-membered heterocyclic systems in place of the thiazole, such as imidazole or oxazole. The conditions for the generation of the corresponding iminoquinomethide type intermediates may be similar or different than the conditions used for the 2-amino-thiazol-5-yl carbinol.
摘要翻译: 本发明提供了制备大环化合物包括大环稳定肽(MSP)的方法。 根据由适当取代的2-氨基 - 噻唑-5-基甲醇产生的亚氨基喹喔啉型中间体的亲核捕获制备大环和MSP。 在大环化合物的情况下,优选的亲核试剂可以选自富含电子的芳族部分,在MSP的情况下,至少一个氨基酸包含富电子的芳族部分。 此外,该概念可以扩展到其它相关的5元杂环体系代替噻唑,例如咪唑或恶唑。 产生相应的亚氨基喹喔啉型中间体的条件可以与用于2-氨基 - 噻唑-5-基甲醇的条件相似或不同。
-
公开(公告)号:US07879855B2
公开(公告)日:2011-02-01
申请号:US12411724
申请日:2009-03-26
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: A61K31/53 , A61P35/00 , C07D487/04 , C07D401/14 , A61P19/02
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制酪氨酸激酶活性,从而使它们用作抗癌剂和治疗阿尔茨海默氏病。
-
公开(公告)号:US20090239838A1
公开(公告)日:2009-09-24
申请号:US12411724
申请日:2009-03-26
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: A61K31/53 , A61P35/00 , A61K31/5377
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制酪氨酸激酶活性,从而使它们用作抗癌剂和治疗阿尔茨海默氏病。
-
公开(公告)号:US4935504A
公开(公告)日:1990-06-19
申请号:US277901
申请日:1988-12-02
IPC分类号: C07H17/04
CPC分类号: C07H17/04 , Y10S514/908
摘要: Novel 4'-esters, 4'-carbonates and 4'-carbamates of 4'-demethylepipodophyllotoxin glucosides are disclosed. These agents exhibit antitumor activity in animals.
摘要翻译: 公开了4'-去甲表鬼臼毒素葡糖苷的新型4'-酯,4'-碳酸酯和4'-氨基甲酸酯。 这些药物在动物中表现出抗肿瘤活性。
-
公开(公告)号:US20110124623A1
公开(公告)日:2011-05-26
申请号:US13015687
申请日:2011-01-28
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: A61K31/397 , A61K31/53 , C07D487/04 , A61K31/5386 , A61K31/5377 , A61K31/551 , A61P35/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制酪氨酸激酶活性,从而使它们用作抗癌剂和治疗阿尔茨海默氏病。
-
公开(公告)号:US07534792B2
公开(公告)日:2009-05-19
申请号:US11773466
申请日:2007-07-05
申请人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
发明人: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
IPC分类号: C07D487/04 , C07D403/12 , C07D403/14 , A61K31/53 , A61P19/02 , A61P35/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制酪氨酸激酶活性,从而使它们用作抗癌剂和治疗阿尔茨海默氏病。
-
-
-
-
-
-
-
-
-